AcelRx Pharmaceuticals Analysis
AcelRx Pharmaceuticals is undervalued with Real Value of 0.0 and Hype Value of 0.0. The main objective of AcelRx Pharmaceuticals delisted stock analysis is to determine its intrinsic value, which is an estimate of what AcelRx Pharmaceuticals is worth, separate from its market price. There are two main types of AcelRx Pharmaceuticals' stock analysis: fundamental analysis and technical analysis.
The AcelRx Pharmaceuticals stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. AcelRx Pharmaceuticals is usually not traded on Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day, Labour Day. AcelRx Stock trading window is adjusted to America/New York timezone.
AcelRx |
AcelRx Stock Analysis Notes
About 39.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.74. Some equities with similar Price to Book (P/B) outperform the market in the long run. AcelRx Pharmaceuticals recorded a loss per share of 2.75. The entity had not issued any dividends in recent years. The firm had 1:20 split on the 26th of October 2022. AcelRx Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of acute pain. AcelRx Pharmaceuticals, Inc. was incorporated in 2005 and is based in Hayward, California. Acelrx Pharmaceutica operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on NASDAQ Exchange. It employs 43 people. For more info on AcelRx Pharmaceuticals please contact Vincent Angotti at 650 216 3500 or go to https://www.acelrx.com.AcelRx Pharmaceuticals Investment Alerts
AcelRx Pharmaceuticals is not yet fully synchronised with the market data | |
AcelRx Pharmaceuticals has some characteristics of a very speculative penny stock | |
AcelRx Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
AcelRx Pharmaceuticals currently holds about 22.92 M in cash with (28.33 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.11. |
AcelRx Pharmaceuticals Upcoming and Recent Events
Earnings reports are used by AcelRx Pharmaceuticals to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period..
4th of April 2024 Upcoming Quarterly Report | View | |
8th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
4th of April 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
AcelRx Market Capitalization
The company currently falls under 'Micro-Cap' category with a current market capitalization of 13.56 M.AcelRx Pharmaceuticals Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific AcelRx Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on AcelRx Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases AcelRx Pharmaceuticals insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Mark Wan over a year ago Acquisition by Mark Wan of 581 shares of AcelRx Pharmaceuticals subject to Rule 16b-3 | ||
Three Arch Management Iv Llc over a year ago Exercise of in-the-money or at-the-money derivative position by Three Arch Management Iv Llc of 117661 shares of AcelRx Pharmaceuticals | ||
Three Arch Management Iv Llc over a year ago Exercise of in-the-money or at-the-money derivative position by Three Arch Management Iv Llc of 2597 shares of AcelRx Pharmaceuticals | ||
Mark Wan over a year ago AcelRx Pharmaceuticals exotic insider transaction detected |
AcelRx Pharmaceuticals Outstanding Bonds
AcelRx Pharmaceuticals issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. AcelRx Pharmaceuticals uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most AcelRx bonds can be classified according to their maturity, which is the date when AcelRx Pharmaceuticals has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
ACE INA HLDGS Corp BondUS00440EAH09 | View | |
ACE INA HLDGS Corp BondUS00440EAQ08 | View | |
Dana 575 percent Corp BondUS235822AB96 | View | |
ACE INA HLDGS Corp BondUS00440EAW75 | View | |
ACE INA HLDGS Corp BondUS00440EAV92 | View | |
ACE INA HLDGS Corp BondUS00440EAS63 | View | |
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 4875 Corp BondUS55336VAJ98 | View |
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding AcelRx Pharmaceuticals to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Idea Breakdown Now
Idea BreakdownAnalyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes |
All Next | Launch Module |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in AcelRx Stock
If you are still planning to invest in AcelRx Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the AcelRx Pharmaceuticals' history and understand the potential risks before investing.
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |